Serum cathelicidin, nasopharyngeal microbiota, and disease severity among infants hospitalized with bronchiolitis - 19/04/17
Doi : 10.1016/j.jaci.2016.09.037
Kohei Hasegawa, MD, MPH a 
, Jonathan M. Mansbach, MD, MPH b, Nadim J. Ajami, PhD c, Joseph F. Petrosino, PhD c, Robert J. Freishtat, MD, MPH d, Stephen J. Teach, MD, MPH d, Pedro A. Piedra, MD e, Carlos A. Camargo, MD, DrPH, FAAAAI a
, Jonathan M. Mansbach, MD, MPH b, Nadim J. Ajami, PhD c, Joseph F. Petrosino, PhD c, Robert J. Freishtat, MD, MPH d, Stephen J. Teach, MD, MPH d, Pedro A. Piedra, MD e, Carlos A. Camargo, MD, DrPH, FAAAAI a a Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Mass
b Department of Medicine, Boston Children's Hospital, Boston, Mass
c Alkek Center for Metagenomics and Microbiome Research, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Tex
d Division of Emergency Medicine and Department of Pediatrics, Children's National Medical Center, Washington, DC
e Department of Molecular Virology and Microbiology and Pediatrics, Baylor College of Medicine, Houston, Tex
| This study was supported by the National Institutes of Health (Bethesda, Md; grant nos. U01 AI-087881, R01 AI-114552, R01 AI-108588, and R21 HL-129909). The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. |
|
| Disclosure of potential conflict of interest: K. Hasegawa receives research support from the National Institutes of Health (NIH). N. J. Ajami and J. F. Petrosino own shares at Diversigen Inc, a microbiome research company. J. M. Mansbach receives research support from the NIH and has provided bronchiolitis-related consultation for Regeneron. S. J. Teach receives grant support from the NIH, Novartis, and EJF Philanthropies. P. A. Piedra provided bronchiolitis-related consultation for Gilead, Novavax, and Regeneron.The rest of the authors declare that they have no relevant conflicts of interest. |
© 2016
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 139 - N° 4
P. 1383 - avril 2017 Retour au numéro
Article précédent
- Dysregulation of lipidomic profile and antiviral immunity in response to hyaluronan in patients with severe asthma
- Milena Sokolowska, Li-Yuan Chen, Yueqin Liu, Asuncion Martinez-Anton, Carolea Logun, Sara Alsaaty, Rosemarie A. Cuento, Rongman Cai, Junfeng Sun, Oswald Quehenberger, Aaron M. Armando, Edward A. Dennis, Stewart J. Levine, James H. Shelhamer
- Association of ORAI1 gene polymorphisms with chronic spontaneous urticaria and the efficacy of the nonsedating H1 antihistamine desloratadine
- Jie Li, Aiyuan Guo, Wangqing Chen, Lianghua Bin, Yijing He, Wu Zhu, Cong Peng, Siyu Yan, Mingliang Chen, Jianglin Zhang, Juan Su, Mei Yi, Zhaoqian Liu, Wei Zhang, Weiqi Zeng, Donald Y.M. Leung, Xiang Chen
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?